DRDO, Indian Army successfully conduct trials of indigenous Man Portable Anti-tank Guided Missile Weapon System

DRDO, Indian Army conduct successful trials of indigenous Man Portable Anti-Tank Guided Missile (MPATGM) Weapon System in Pokhran
DRDO & Indian Army conduct successful trials of indigenous Man Portable Anti-Tank Guided Missile (MPATGM) Weapon System. Photo Courtesy: PIB

The Defence Research and Development Organisation (DRDO) has concluded successful developmental trials of its domestically developed Man-Portable Anti-Tank Guided Missile (MPATGM) system in Rajasthan’s Pokhran.

The system consisted of the MPATGM, Launcher, Target Acquisition System, and the Fire Control Unit.

“Adequate number of missile firing trials have been successfully conducted towards achieving compliance with complete operational envelop as stipulated in the General Staff Qualitative Requirements (Infantry, Indian Army),” the Indian government said in a statement.

“The Warhead Flight Trials were successfully conducted at the Pokhran Field Firing Range, Rajasthan on April 13, 2024. Missile performance and warhead performance were found to be remarkable,” the statement said.

Penetration trials of the Tandem Warhead System of MPATGM have been successfully completed and it is found capable of defeating modern armour protected Main Battle Tank.

The ATGM system is well-equipped with day/night and top attack capability.

Dual mode seeker functionality is a great value addition to the missile capability for tank warfare.

With this, technology development and successful demonstration have been concluded and the system is now ready for Final User Evaluation Trials leading towards its induction into the Indian Army.

Indian Defence Minister Rajnath Singh has complimented the DRDO and the Indian Army for the successful trials of the system, terming it as an important step towards achieving self-reliance in advanced technology-based defence system development.

Secretary, Department of Defence R&D and Chairman DRDO Dr Samir V Kamat also congratulated the teams associated with the trials.